Dr. Reddy's launches toripalimab in India
It is the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma.cd
It is the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma.cd
Event to highlight breadth of innovative capabilities, solutions and strategic partnerships that support healthcare continuum.
NACDS urges action this year to address "America's complicated - and costly - system for paying for medicines" as described in the article.
New York State Department of Financial Services adopts new market conduct regulations that will enable the regulatory oversight, transparency and accountability of PBMs operating in the state.
GlobalData warns that President-elect Trump's proposed tariffs could raise prices and disrupt access to 75% of U.S. medical devices.
Move would also ensure access to the medications for approximately 4 million adult Medicaid enrollees.
BridgeBio Pharma has received FDA approval for a new drug for a rare heart disease after very promising trials.
Governor Kathy Hochul announced new regulations to govern Pharmacy Benefit Managers in New York. They aim to reduce prescription drug costs, increase transparency, and support small, independent pharmacies.
Johnson & Johnson has submitted an FDA application for the first subcutaneous IL-23 inhibitor for ulcerative colitis. This drug could offer patients a groundbreaking at-home treatment option.
A recent NACDS poll highlights strong voter support for PBM reform and the significant influence healthcare issues had on voters' decisions in the 2024 elections.
This is the latest move in a bitter legal fight between the three largest pharmacy benefit managers, or PBMs, in the U.S. and the FTC.
The latest Factbook reveals that approximately 95 percent of all pharmaceutical sales moved through the traditional distribution segment in 2023, among other key findings.
The announcement was made by CEO Kevin Murphy, who highlighted Stalbaum’s extensive experience and contributions to the company since joining in 2019.
Bruce Kneeland, Principal Consultant of Kneeland Services and industry expert, has joined Finch Marketing and GRX Marketing to drive its growth initiatives.